Robert E Black Selected Research

Measles Vaccine

11/2017	Available studies fail to provide strong evidence of increased risk of diarrhea mortality due to measles in the period 4-26 weeks after measles rash onset.
8/2016	Multistakeholder partnerships with the Democratic Peoples' Republic of Korea to improve childhood immunisation: A perspective from global health equity and political determinants of health equity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert E Black Research Topics

Disease

49	Diarrhea 01/2022 - 01/2003
29	Pneumonia (Pneumonitis) 01/2020 - 01/2003
22	Infections 01/2019 - 12/2002
16	Malaria 01/2021 - 01/2003
13	Growth Disorders 03/2022 - 09/2007
9	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 09/2005
9	Malnutrition (Nutritional Deficiencies) 01/2021 - 05/2004
8	Meningitis 01/2022 - 12/2003
8	Anemia 01/2022 - 10/2004
7	Communicable Diseases (Infectious Diseases) 01/2014 - 01/2003
6	Birth Weight (Birth Weights) 01/2021 - 05/2004
5	Dysentery 03/2011 - 07/2004
4	Measles 01/2022 - 04/2010
3	Perinatal Death 09/2020 - 02/2010
3	Typhoid Fever (Typhoid) 01/2018 - 10/2006
3	Vitamin A Deficiency 09/2015 - 08/2005
3	Dehydration (Water Stress) 08/2015 - 04/2010
3	Vomiting 08/2015 - 05/2006
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 08/2015 - 02/2008
3	Iron Deficiencies 01/2015 - 01/2013
3	Diphtheria 01/2014 - 10/2006
3	Whooping Cough (Pertussis) 01/2014 - 10/2006
3	Sepsis (Septicemia) 01/2013 - 03/2008
3	Cross Infection (Nosocomial Infection) 01/2013 - 03/2005
3	Weight Gain 09/2010 - 12/2002
2	Stillbirth 03/2022 - 01/2021
2	Premature Birth (Birth, Premature) 03/2022 - 01/2017
2	Inflammation (Inflammations) 01/2022 - 08/2005
2	Neural Tube Defects (Exencephaly) 01/2018 - 01/2015
2	Parasitemia 01/2015 - 04/2006
2	Neonatal Sepsis 04/2014 - 08/2013
2	Tetanus 01/2014 - 10/2007
2	Vitamin D Deficiency 12/2012 - 10/2010
2	Bacteremia 01/2012 - 09/2009
2	Fever (Fevers) 06/2008 - 07/2007
2	Tuberculosis (Tuberculoses) 07/2007 - 01/2004
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022
1	COVID-19 01/2022
1	Overweight 01/2021
1	Obesity 01/2021
1	Pediatric Obesity 01/2021
1	Syphilis 01/2021
1	Wounds and Injuries (Trauma) 01/2017
1	Overnutrition 01/2017
1	Congenital Abnormalities (Deformity) 01/2017
1	Poliomyelitis (Polio) 08/2016
1	Fetal Distress 06/2016

Drug/Important Bio-Agent (IBA)

67	ZincIBA 01/2022 - 12/2002
17	IronIBA 01/2022 - 12/2003
17	ORALIT (ORS)IBA 12/2019 - 07/2004
17	Anti-Bacterial Agents (Antibiotics)IBA 05/2015 - 12/2003
16	VaccinesIBA 01/2022 - 12/2003
15	Vitamin A (Retinol)FDA LinkGeneric 12/2019 - 01/2004
13	MicronutrientsIBA 01/2022 - 12/2003
12	SaltsIBA 12/2016 - 07/2004
9	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 08/2004
7	Rotavirus VaccinesIBA 12/2019 - 04/2010
6	Indicators and Reagents (Reagents)IBA 01/2015 - 01/2004
5	TabletsIBA 01/2018 - 11/2005
4	Conjugate VaccinesIBA 12/2016 - 10/2006
3	SolutionsIBA 12/2019 - 11/2005
3	VitaminsIBA 01/2014 - 03/2004
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 08/2005
2	Measles VaccineIBA 11/2017 - 08/2016
2	ChlorhexidineIBA 12/2015 - 01/2013
2	IodineIBA 01/2015 - 08/2013
2	Therapeutic UsesIBA 06/2013 - 02/2008
2	Cholecalciferol (Vitamin D3)FDA Link 03/2013 - 12/2012
2	OligosaccharidesIBA 09/2010 - 08/2010
2	PrebioticsIBA 09/2010 - 08/2010
2	insulin receptor-related receptor (IRR)IBA 06/2010 - 03/2005
2	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2010 - 10/2006
2	Penicillins (Penicillin)FDA Link 09/2009 - 12/2003
2	Pharmaceutical PreparationsIBA 06/2008 - 11/2005
2	BCG Vaccine FDA Link 10/2007 - 10/2006
2	LatexIBA 12/2006 - 02/2005
1	A 103 (A-103)IBA 03/2022
1	MetalsIBA 03/2022
1	MineralsIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	A 17 (A-17)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	N- (3,5- dichlorophenyl)- 2- hydroxysuccinimideIBA 09/2020
1	Blood Group Antigens (Blood Groups)IBA 01/2019
1	FucosyltransferasesIBA 01/2019
1	PowdersIBA 01/2018
1	Drinking WaterIBA 01/2018
1	Bacterial VaccinesIBA 10/2017
1	Combined VaccinesIBA 08/2016
1	Japanese Encephalitis VaccinesIBA 08/2016
1	Surface-Active Agents (Surfactants)IBA 06/2016
1	Tocolytic Agents (Tocolytics)IBA 06/2016

Therapy/Procedure

16	Fluid Therapy (Oral Rehydration Therapy) 12/2019 - 07/2004
10	Therapeutics 01/2021 - 07/2004
3	Injections 05/2015 - 11/2005
1	Preconception Care 01/2021
1	Prenatal Care (Care, Prenatal) 01/2021
1	Continuity of Patient Care 09/2020
1	X-Ray Film 01/2018
1	Secondary Prevention 01/2017